|
1.
|
Zur Hausen H: Papillomavirus infections: a
major cause of human cancers. Biochim Biophys Acta. 1288:F55–F78.
1996.PubMed/NCBI
|
|
2.
|
Mitchell MF, Tortolero-Luna G, Wright T,
Sarkar A, Richards-Kortum R, Hong WK and Schottenfeld D: Cervical
human papillomavirus infection and intraepithelial neoplasia: a
review. J Natl Cancer Inst Monogr. 21:17–25. 1996.PubMed/NCBI
|
|
3.
|
Ostor AG: Natural history of cervical
intraepithelial neoplasia: a critical review. Int J Gynecol Pathol.
12:186–192. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Wright TC Jr, Massad LS, Dunton CJ,
Spitzer M, Wilkinson EJ and Solomon D: 2006 American Society for
Colposcopy and Cervical Pathology-sponsored Consensus Conference.
2006 consensus guidelines for the management of women with abnormal
cervical cancer screening tests. Am J Obstet Gynecol. 197:346–355.
2007.
|
|
5.
|
Gestione della paziente con Pap test
anormale: Linee guida 2006 a cura della Società Italiana di
Colposcopia e Patologia Cervico Vaginale (SICPCV). (1st edition).
Articoli Editore. Modena. 21:2–26. 2006.
|
|
6.
|
Jordan J, Martin-Hirsch P, Arbyn M,
Schenck U, Baldauf JJ, da Silva D, Anttila A, Nieminen P and
Prendiville W: European guidelines for clinical management of
abnormal cervical cytology, Part 2. Cytopathology. 20:5–16. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr and
Young N; Forum Group Members; Bethesda 2001 Workshop: The 2001
Bethesda system: terminology for reporting results of cervical
cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Solomon D, Schiffman M and Tarone R; ALTS
Group: Comparison of three management strategies for patients with
atipical squamous cells of undetermined significance: baseline
results from a randomized trial. J Natl Cancer Inst. 93:293–299.
2001. View Article : Google Scholar
|
|
9.
|
ASCUS-LSIL Triage study Group: Results of
a randomized trial on the management of cytology interpretations of
atypical squamous cells of undetermined significance. Am J Obstet
Gynecol. 188:1382–1392. 2003.
|
|
10.
|
Ortega S, Malumbres M and Barbacid M:
Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim
Biophys Acta. 1602:73–87. 2002.PubMed/NCBI
|
|
11.
|
Yugawa T and Kiyono T: Molecular
mechanisms of cervical carcinogenesis by high-risk human
papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev
Med Virol. 19:97–113. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Khleif SN, DeGregori J, Yee CL, Otterson
GA, Kaye FJ, Nevins JR and Howley PM: Inhibition of cyclin
D-CDK4/CDK6 activity is associated with an E2F-mediated induction
of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA.
93:4350–4354. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Klaes R, Friedrich T, Spitkovsky D, Ridder
R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D and von Knebel
Doeberitz M: Overexpression of p16(INK4A) as a specific marker for
dysplastic and neoplastic epithelial cells of the cervix uteri. Int
J Cancer. 92:276–284. 2001. View
Article : Google Scholar
|
|
14.
|
Von Knebel Doeberitz M: New markers for
cervical dysplasia to visualise the genomic chaos created by
aberrant oncogenic Papillomavirus infections. Eur J Cancer.
38:2229–2242. 2002.PubMed/NCBI
|
|
15.
|
Baak JP, Kruse AJ, Robboy SJ, Janssen EAM,
van Diermen B and Skaland I: Dynamic behavioural interpretation of
cervical intraepithelial neoplasia with molecular biomarkers. J
Clin Pathol. 59:1017–1028. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Trunk MJ, Dallenbach-Hellweg G, Ridder R,
Petry KU, Ikenberg H, Schneider V and von Knebel Doeberitz M:
Morphologic characteristics of p16INK4a-positive cells in cervical
cytology samples. Acta Cytol. 48:771–782. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Dehn D, Torkko KC and Shroyer KR: Human
papillomavirus testing and molecular markers of cervical dysplasia
and carcinoma. Cancer Cytopathol. 111:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Schledermann D, Andersen BT, Bisgaard K,
Dohse M, Ejersbo D, Hoelund B, Horal P, Lindh M and Ryd W: Are
adjunctive markers useful in routine cervical cancer screening?
Application of ThinPrep samples with histological follow-up. Diagn
Cytopathol. 36:453–459. 2008. View
Article : Google Scholar
|
|
19.
|
Manual CINtec MTM: http://www.mtmlabs.comuri.
|
|
20.
|
Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen
N, Koliopoulos G, Martin-Hirsch P, Malamou-Mitsi V and
Paraskevaidis E: p16(INK4a) immunostaining in cytological and
histological specimens from the uterine cervix: a systematic review
and meta-analysis. Cancer Treat Rev. 35:210–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Hariri J and Oster A: The negative
predictive value of p16INK4a to assess the outcome of cervical
intraepithelial neoplasia in the uterine cervix. Int J Gynecol
Pathol. 26:223–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Rocha AS, Bozzetti MC, Kirschnick LS and
Edelweiss M: Antibody anti-p16 (INK4a) in cervical cytology. Acta
Cytol. 53:253–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Negri G, Vittadello F, Romano F, Kasal A,
Rivasi F, Girlando S, Mian C and Egarter-Vigl E: P16INK4a
expression and progression risk of low-grade intraepithelial
neoplasia of the cervix uteri. Virchows Arch. 445:616–620. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Alsharif M, Kjeldahl K, Curran C, Miller
S, Gulbahce HE and Pambuccian SE: Clinical significance of the
diagnosis of low-grade squamous intraepithelial lesion, cannot
exclude high-grade squamous intraepithelial lesion. Cancer
Cytopathol. 117:92–100. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Al-Nourhji O, Beckmann MJ, Markwell SJ and
Massad LS: Pathology correlates of a Papanicolaou diagnosis of
low-grade squamous intraepithelial lesion, cannot exclude
high-grade squamous intraepithelial lesion. Cancer. 114:469–473.
2008. View Article : Google Scholar
|
|
26.
|
Wentzensen N, Bergeron C, Cas F,
Vinokurova S and von Knebel Doeberitz M: Triage of women with ASCUS
and LSIL cytology: use of qualitative assessment of
p16INK4a-positive cells to identify patients with high-grade
cervical intraepithelial neoplasia. Cancer. 111:58–66. 2007.
View Article : Google Scholar
|
|
27.
|
Castle PE, Schiffman M, Wheeler C and
Solomon D: Evidence for frequent regression of cervical
intraepithelial neoplasia-grade 2. Obstet Gynecol. 113:18–25. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Carcopino X, Muszynski C, Merfui J-L,
Gondry J and Boubli L: Should CIN2 and 3 be treated the same way?
Gynecol Obstet Fertil. 39:94–99. 2011.PubMed/NCBI
|
|
29.
|
Stoller MH and Schiffman M: Interobserver
reproducibility of cervical cytology and histologic
interpretations: realistic estimates from the ASCUS-LSIL Triage
Study. JAMA. 285:1500–1505. 2001. View Article : Google Scholar
|
|
30.
|
Bergeron C, Ordi J, Schmidt D, Trunk MJ,
Keller T and Ridder R: European CINtec Histology Study Group.
Conjunctive p16INK4a testing significantly increases accuracy in
diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin
Pathol. 133:395–406. 2010. View Article : Google Scholar
|
|
31.
|
Kurshumliu F, Thorns C and Gashi-Luci L:
p16INK4A in routine practice as a marker of cervical epithelial
neoplasia. Gynecol Oncol. 115:127–131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Galgano MT, Castle PE, Atkins KA, Brix WK,
Nassau SR and Stoler MH: Using biomarkers as objective standards in
the diagnosis of cervical biopsies. Am J Surg Pathol. 34:1077–1087.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Monsonego J, Pollini G, Evrard MJ,
Sednaoui P, Monfort L, Quinzat D, Dachez R and Syrjänen K: P16INK4a
immunocytochemistry in liquid-based cytology samples in equivocal
Pap smears: added value in management of women with equivocal Pap
smear. Acta Cytol. 51:755–766. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Nieh S, Chen SF, Chu TY, Lai HC, Lin YS,
Fu E and Gau CH: Is p16 (INK4A) expression more useful than human
papillomavirus test to determine the outcome of atypical squamous
cells of undetermined significance-categorized Pap smear? A
comparative analysis using abnormal cervical smears with follow-up
biopsies. Gynecol Oncol. 97:35–40. 2005. View Article : Google Scholar
|
|
35.
|
Eleutério J Jr, Giraldo PC, Gonçalves AK,
Cavalcante DI, de Almeida Ferreira FV, Mesquita SM and Morais SS:
Prognostic markers of high-grade squamous intraepithelial lesions:
the role of p16INK4a and high-risk human papillomavirus. Acta
Obstet Gynecol Scand. 86:94–98. 2007.
|
|
36.
|
Furtado YL, Almeida G, Lattario F, Silva
KS, Maldonado P, Silveira FA, do Val IC, Fonseca R and Carvalho Mda
G: The presence of methylation of the p16INK4A gene and human
papillomavirus in high-grade cervical squamous intraepithelial
lesions. Diagn Mol Pathol. 19:15–19. 2010. View Article : Google Scholar
|
